GeneDx Holdings Corp
WGS84.290USD
+0.210+0.25%
Cierre 02/06, 16:00（ET）Cotizaciones retrasadas 15 min
2.44BCap. mercado
776.72P/E TTM
Más Datos de GeneDx Holdings Corp Compañía
GeneDx Holdings Corp. is a genomics company. The Company operates, through its subsidiary, GeneDx, LLC, which is focused on exome and genome tests that translate complex genomic data into clinical answers that unlock personalized health plans, accelerate drug discovery, and improve health system efficiencies. It operates through GeneDx segment, which primarily provides pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing and, to a lesser extent, data and information services. Exome sequencing test options include XomeDx, XomeDx Plus, and XomeDxXpress. GeneDx genome sequencing evaluates the protein-coding and non-coding regions of an individual’s nuclear genome. GeneDx genome sequencing test options include GenomeSeqDx and GenomeXpress. It offers a menu of targeted variant testing options to meet the needs of families and healthcare providers. Its subsidiary, Fabric Genomics, Inc., specializes in artificial intelligence-powered genomic interpretation.
Información de GeneDx Holdings Corp
Símbolo de cotizaciónWGS
Nombre de la empresaGeneDx Holdings Corp
Fecha de salida a bolsaSep 04, 2020
Director ejecutivoStueland (Katherine A)
Número de empleados1000
Tipo de seguridadOrdinary Share
Fin del año fiscalSep 04
Dirección333 Ludlow Street
CiudadSTAMFORD
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal06902
Teléfono18887291206
Sitio Webhttps://sema4.com/
Símbolo de cotizaciónWGS
Fecha de salida a bolsaSep 04, 2020
Director ejecutivoStueland (Katherine A)
Ejecutivos de GeneDx Holdings Corp
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Joshua Ruch
Mr. Joshua Ruch
Independent Director
Independent Director
223.99K
+12924.00%
Dr. Emily M. Leproust, Ph.D.
Dr. Emily M. Leproust, Ph.D.
Independent Director
Independent Director
33.16K
+12924.00%
Mr. Kevin Feeley
Mr. Kevin Feeley
Chief Financial Officer
Chief Financial Officer
9.43K
+437.00%
Dr. Bryan Dechairo
Dr. Bryan Dechairo
Chief Operating Officer
Chief Operating Officer
5.96K
+5961.00%
Mr. Keith A. Meister
Mr. Keith A. Meister
Independent Director
Independent Director
3.58K
-16553.00%
Mr. Jason Michael Ryan, CPA
Mr. Jason Michael Ryan, CPA
Chairman of the Board
Chairman of the Board
--
--
Mr. Eli D. Casdin
Mr. Eli D. Casdin
Independent Director
Independent Director
--
--
Mr. Richard C. (Rick) Pfenniger, Jr.
Mr. Richard C. (Rick) Pfenniger, Jr.
Independent Director
Independent Director
--
--
Ms. Katherine A. Stueland
Ms. Katherine A. Stueland
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Dr. Thomas Fuchs
Dr. Thomas Fuchs
Director
Director
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Joshua Ruch
Mr. Joshua Ruch
Independent Director
Independent Director
223.99K
+12924.00%
Dr. Emily M. Leproust, Ph.D.
Dr. Emily M. Leproust, Ph.D.
Independent Director
Independent Director
33.16K
+12924.00%
Mr. Kevin Feeley
Mr. Kevin Feeley
Chief Financial Officer
Chief Financial Officer
9.43K
+437.00%
Dr. Bryan Dechairo
Dr. Bryan Dechairo
Chief Operating Officer
Chief Operating Officer
5.96K
+5961.00%
Mr. Keith A. Meister
Mr. Keith A. Meister
Independent Director
Independent Director
3.58K
-16553.00%
Mr. Jason Michael Ryan, CPA
Mr. Jason Michael Ryan, CPA
Chairman of the Board
Chairman of the Board
--
--
Desglose de ingresos
Divisa: USDActualizado: mar., 6 de ene
Divisa: USDActualizado: mar., 6 de ene
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Por negocioUSD
Nombre
Ganancia
Proporción
Patients with third party insurance
95.02M
81.39%
Institutional customers
17.87M
15.31%
Other
3.22M
2.76%
Self pay patients
629.00K
0.54%
La empresa aún no ha revelado los datos relevantes.
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Patients with third party insurance
95.02M
81.39%
Institutional customers
17.87M
15.31%
Other
3.22M
2.76%
Self pay patients
629.00K
0.54%
Estadísticas de accionistas
Actualizado: sáb., 31 de ene
Actualizado: sáb., 31 de ene
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Corvex Management LP
10.58%
Casdin Capital, LLC
10.40%
Icahn School of Medicine at Mount Sinai
4.75%
OPKO Health Inc
4.74%
BlackRock Institutional Trust Company, N.A.
4.56%
Otro
64.96%
Accionistas
Accionistas
Proporción
Corvex Management LP
10.58%
Casdin Capital, LLC
10.40%
Icahn School of Medicine at Mount Sinai
4.75%
OPKO Health Inc
4.74%
BlackRock Institutional Trust Company, N.A.
4.56%
Otro
64.96%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor/Hedge Fund
33.56%
Investment Advisor
33.01%
Hedge Fund
30.92%
Corporation
10.65%
Research Firm
6.77%
Individual Investor
1.69%
Pension Fund
0.74%
Venture Capital
0.31%
Sovereign Wealth Fund
0.29%
Participación institucional
Actualizado: mié., 21 de ene
Actualizado: mié., 21 de ene
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2026Q4
456
30.28M
113.16%
--
2025Q4
496
30.67M
106.12%
-3.46M
2025Q3
446
32.52M
112.51%
-918.42K
2025Q2
397
34.23M
119.24%
+1.02M
2025Q1
398
32.79M
115.46%
-47.86K
2024Q4
341
29.17M
104.22%
+1.72M
2024Q3
289
26.18M
97.50%
+377.48K
2024Q2
262
24.98M
95.33%
+588.25K
2024Q1
260
22.13M
86.19%
+1.41M
2023Q4
271
20.57M
80.67%
-567.28K
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Corvex Management LP
3.06M
10.58%
--
--
Sep 30, 2025
Casdin Capital, LLC
3.01M
10.4%
-38.49K
-1.26%
Sep 30, 2025
Icahn School of Medicine at Mount Sinai
1.37M
4.75%
-1.35M
-49.50%
Feb 21, 2025
OPKO Health Inc
1.37M
4.74%
-800.83K
-36.88%
Nov 20, 2024
BlackRock Institutional Trust Company, N.A.
1.32M
4.56%
+37.99K
+2.97%
Sep 30, 2025
William Blair Investment Management, LLC
1.22M
4.22%
-411.26K
-25.21%
Sep 30, 2025
The Vanguard Group, Inc.
1.17M
4.03%
-10.50K
-0.89%
Sep 30, 2025
Goldman Sachs & Company, Inc.
1.00M
3.47%
+28.59K
+2.94%
Sep 30, 2025
Oracle Investment Management, Inc.
889.95K
3.08%
-32.50K
-3.52%
Sep 30, 2025
Summit Partners Public Asset Management, LLC
823.57K
2.85%
+56.30K
+7.34%
Sep 30, 2025
Ver más
ETFs relacionados
Actualizado: sáb., 6 de dic
Actualizado: sáb., 6 de dic
Nombre
Proporción
Global X Genomics & Biotechnology ETF
3.84%
Franklin Genomic Advancements ETF
3.47%
Clough Hedged Equity ETF
2.89%
Clough Select Equity ETF
2.65%
State Street SPDR S&P Health Care Services ETF
2.27%
Harbor Health Care ETF
1.85%
Innovator IBD Breakout Opportunities ETF
1.52%
ARK Genomic Revolution ETF
1.29%
Main Thematic Innovation ETF
1.29%
Invesco Dorsey Wright Healthcare Momentum ETF
1.18%
Ver más
Global X Genomics & Biotechnology ETF
Proporción3.84%
Franklin Genomic Advancements ETF
Proporción3.47%
Clough Hedged Equity ETF
Proporción2.89%
Clough Select Equity ETF
Proporción2.65%
State Street SPDR S&P Health Care Services ETF
Proporción2.27%
Harbor Health Care ETF
Proporción1.85%
Innovator IBD Breakout Opportunities ETF
Proporción1.52%
ARK Genomic Revolution ETF
Proporción1.29%
Main Thematic Innovation ETF
Proporción1.29%
Invesco Dorsey Wright Healthcare Momentum ETF
Proporción1.18%
Dividendos
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Fecha ex-dividendo
Tipo
Relación
Apr 28, 2023
Merger
33→1
Apr 28, 2023
Merger
33→1
Apr 28, 2023
Merger
33→1
Apr 28, 2023
Merger
33→1
Fecha
Fecha ex-dividendo
Tipo
Relación
Apr 28, 2023
Merger
33→1
Apr 28, 2023
Merger
33→1
Apr 28, 2023
Merger
33→1
Apr 28, 2023
Merger
33→1
